Home › Compare › ORXOF vs MCD

ORXOF vs MCD: Dividend Comparison 2026

ORXOF yields 87.48% · MCD yields 2.34%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORXOF wins by $2.23M in total portfolio value
10 years
ORXOF
ORXOF
● Live price
87.48%
Share price
$2.29
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.30M
Annual income
$708,964.09
Full ORXOF calculator →
MCD
McDonald's Corporation
● Live price
2.34%
Share price
$310.79
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$25,833.37
Full MCD calculator →

Portfolio growth — ORXOF vs MCD

📍 ORXOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORXOFMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORXOF + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ORXOF pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORXOF
Annual income on $10K today (after 15% tax)
$7,435.92/yr
After 10yr DRIP, annual income (after tax)
$602,619.48/yr
MCD
Annual income on $10K today (after 15% tax)
$198.56/yr
After 10yr DRIP, annual income (after tax)
$21,958.36/yr
At 15% tax rate, ORXOF beats the other by $580,661.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORXOF + MCD for your $10,000?

ORXOF: 50%MCD: 50%
100% MCD50/50100% ORXOF
Portfolio after 10yr
$1.19M
Annual income
$367,398.74/yr
Blended yield
30.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

ORXOF
No analyst data
Altman Z
-0.2
Piotroski
3/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+13.2% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORXOF buys
0
MCD buys
0
No recent congressional trades found for ORXOF or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORXOFMCD
Forward yield87.48% ✓2.34%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$2.30M$77.7K ✓
Annual income after 10y$708,964.09 ✓$25,833.37
Total dividends collected$2.02M$57.7K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: ORXOF vs MCD ($10,000, DRIP)

YearORXOF PortfolioORXOF Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$19,448$8,748.14$10,812$332.41+$8.6K → ORXOF
2$36,710$15,900.47$11,819$488.02+$24.9K → ORXOF
3$67,330$28,049.97$13,111$724.37+$54.2K → ORXOF
4$120,123$48,080.71$14,832$1,091.05+$105.3K → ORXOF
5$208,701$80,169.36$17,219$1,675.85+$191.5K → ORXOF
6$353,484$130,173.43$20,688$2,641.85+$332.8K → ORXOF
7$584,283$206,054.85$25,990$4,309.70+$558.3K → ORXOF
8$943,494$318,311.52$34,590$7,351.77+$908.9K → ORXOF
9$1,489,918$480,379.75$49,535$13,285.25+$1.44M → ORXOF
10$2,303,177$708,964.09$77,746$25,833.37+$2.23M → ORXOF

ORXOF vs MCD: Complete Analysis 2026

ORXOF — Stock

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.

Full ORXOF Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this ORXOF vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORXOF vs SCHDORXOF vs JEPIORXOF vs OORXOF vs KOORXOF vs MAINORXOF vs YUMORXOF vs QSRORXOF vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.